Immune Promotion of Epithelial-mesenchymal Transition and Generation of Breast Cancer Stem Cells
Open Access
- 14 April 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (8), 3005-3008
- https://doi.org/10.1158/0008-5472.can-09-4041
Abstract
Elements of the immune system act as intimate regulators of cancer progression, inhibiting early stages of tumor growth, through immunosurveillance while facilitating later stages of tumor progression. Recent findings have revealed that activated CD8 T cells can stimulate mammary epithelial tumor cells to undergo epithelial-mesenchymal transition (EMT) and to acquire the greatly increased tumorigenic capability and chemotherapeutic resistance of breast cancer stem cells (BCSC). These studies provide a window to understanding how BCSC arise and are maintained within tumors, and how to best target these processes for therapeutic benefit. Cancer Res; 70(8); 3005–8. ©2010 AACR.Keywords
This publication has 27 references indexed in Scilit:
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences of the United States of America, 2009
- Immunoediting of Cancers May Lead to Epithelial to Mesenchymal TransitionPublished by The American Association of Immunologists ,2006
- Inflammation, a Key Event in Cancer DevelopmentMolecular Cancer Research, 2006
- De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependentCancer Cell, 2005
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Socializing with the Neighbors: Stem Cells and Their NicheCell, 2004
- Chronic Renal Allograft DysfunctionJournal of the American Society of Nephrology, 2004
- Mechanisms, mechanics and function of epithelial–mesenchymal transitions in early developmentMechanisms of Development, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994